•🧬GLP-1SG for research use only:
Secure high analytical consistency for your multi-receptor screening layouts. This premium-grade synthesized chemical standard acts as an integrated reference tool designed to evaluate functional incretin-mimetic kinetics and compound coordination cascades cleanly across target cell line setups.
•📊1. Verified Sequence Specifications
| Compound Blueprint: | GLP-1SG Reference Standard Presentation (Sequence 1-31 Area) |
| CAS Registry Code: | 910463-68-2 (For Strict Analytical Traceability Records) |
| Molecular Formula Base: | C187H291N45O59 (Corresponding to the SEMA Sequence Backbone) |
| Purity Level Trace: | ≥98% Pure Confirmed via High-Performance Liquid Chromatography |
| Net Content Value: | 10mg High-Purity Lyophilized Powder Present per Glass Vial |
| Application Profile: | Synthesized Chemical Supplier Reagent for In-Vitro Benchtop Research Only |
•⚙️2. Preclinical Handling & Stability
Advanced solid-phase peptide manufacturing methods secure total batch uniformity and material stability across each unique lot number. To protect the core structural links from premature sequence cleavage or degradation, store the dry lyophilized powder tightly sealed inside your freezer environment under continuous climate control at -20°C, ensuring the glass container remains completely clear of light and moisture. Following reconstitution with proper sterile solvents under clean laboratory procedures, handle the liquid matrix according to established laboratory protocols. Move fluid stock samples immediately to refrigerator units at 2-8°C to secure data accuracy throughout the screening assay window. Fast domestic shipping channels manage transport quickly to maintain optimal chemical longevity upon arrival.
•🔬3. Research Mechanisms & Preclinical FAQ
•🛡️What specific pathways are evaluated using this single-sequence SEMA reference layout?
Preclinical literature monitors this compound for its functional agonism at the glucagon-like peptide-1 receptor system. In-vitro models implement the sequence to evaluate downstream signaling thresholds, cyclic-AMP co-activation readouts, and concentration-dependent binding stability within controlled bench testing systems.
•📋How do investigators verify batch transparency before executing an assay layout?
Every reference batch connects directly to its lot-matched Certificate of Analysis (COA). Independent testing networks verify target molecular mass distributions via mass spectrometry and confirm a purity threshold of at least 98 percent through reversed-phase HPLC to guarantee experimental reproducibility.
99% Purity Guaranteed
Independent Lab Tested
⚠️ FDA DISCLAIMER: These products are intended strictly for laboratory research use only. They are not intended for human consumption, diagnostic, or therapeutic purposes. The statements on this website have not been evaluated by the Food and Drug Administration.
